Tear Sheet: VMED O2 UK Ltd. - S&P Global Ratings’ Credit Research

Tear Sheet: VMED O2 UK Ltd.

Tear Sheet: VMED O2 UK Ltd. - S&P Global Ratings’ Credit Research
Tear Sheet: VMED O2 UK Ltd.
Published Apr 30, 2026
7 pages (3161 words) — Published Apr 30, 2026
Price US$ 500.00  |  Buy this Report Now

About This Report

  
Abstract:

This report does not constitute a rating action. VMED O2 UK's credit metrics are expected to remain within acceptable rating thresholds, although with reduced headroom, reflecting weaker-than-anticipated prospective earnings. S&P Global Ratings projects an organic revenue decline of approximately 4%, driven by increased promotional activity within the consumer mobile segment and ongoing pricing pressures in the highly fragmented consumer fixed market. Consequently, we forecast a 4%-6% decline in overall consumer segment revenue in 2026, attributable to weakness in both fixed and mobile services. Furthermore, we anticipate organic revenue from the business-to-business (B2B) segment will also decrease in 2026, as planned streamlining of the product portfolio introduces a temporary headwind. This revenue decline is expected to translate into a 3%-4% reduction

  
Brief Excerpt:

...April 30, 2026 This report does not constitute a rating action. VMED O2 UK's credit metrics are expected to remain within acceptable rating thresholds, although with reduced headroom, reflecting weaker-than-anticipated prospective earnings. S&P Global Ratings projects an organic revenue decline of approximately 4%, driven by increased promotional activity within the consumer mobile segment and ongoing pricing pressures in the highly fragmented consumer fixed market. Consequently, we forecast a 4%-6% decline in overall consumer segment revenue in 2026, attributable to weakness in both fixed and mobile services. Furthermore, we anticipate organic revenue from the business-to-business (B2B) segment will also decrease in 2026, as planned streamlining of the product portfolio introduces a temporary headwind. This revenue decline is expected to translate into a 3%-4% reduction in organic adjusted EBITDA, resulting in an adjusted debt-to-EBITDA ratio approaching 6.0x by the end of 2026. We believe...

  
Report Type:

Full Report

Issuer
Sector
Global Issuers
Country
Region
Europe, Middle East, Africa
Format:
PDF Adobe Acrobat
Buy Now

S&P Global Ratings’ Credit Research—S&P Global Ratings’ credit research provides analysis on issuers and debt obligations of corporations, states and municipalities, financial institutions, insurance companies and sovereign governments. S&P Global Ratings also offers insight into the credit risk of structured finance deals, providing an independent view of credit risk associated with a growing array of debt-securitized instruments.

About the Author


Cite this Report

  
MLA:
S&P Global Ratings’ Credit Research. "Tear Sheet: VMED O2 UK Ltd." Apr 30, 2026. Alacra Store. Nov 07, 2026. <http://www.alacrastore.com/s-and-p-credit-research/Tear-Sheet-VMED-O2-UK-Ltd-3554627>
  
APA:
S&P Global Ratings’ Credit Research. (). Tear Sheet: VMED O2 UK Ltd. Apr 30, 2026. New York, NY: Alacra Store. Retrieved Nov 07, 2026 from <http://www.alacrastore.com/s-and-p-credit-research/Tear-Sheet-VMED-O2-UK-Ltd-3554627>
  
US$ 500.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.